Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report.

Kidney Int · 2021 · PMC8375247 · PMID 34419552

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

marginally significantP = 0.051so close (0.05 < p ≤ 0.1)

There was also a marginally significant trend of greater seroconversion rates among healthy controls than patients with ESKD (100% vs. 88%; P = 0.051).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.